Sentinel Lymph Node Detection in Early-Stage Oral Squamous Cell Carcinoma Using Magnetic Resonance Lymphography: A Pilot Study
Authors:
- Dominique N. V. DondersDominique N. V. Donders
- Rutger MahieuRutger Mahieu
- Roosmarijn S. TellmanRoosmarijn S. Tellman
- Marielle E. P. PhilippensMarielle E. P. Philippens
- Robert J. J. van EsRobert J. J. van Es
- Ellen M. Van CannEllen M. Van Cann
- Gerben E. BreimerGerben E. Breimer
- Remco de BreeRemco de Bree
- Bart de KeizerBart de Keizer
Open Access
- 22 November 2024
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (23) , 7052
Abstract
Objectives: To assess the efficacy of magnetic resonance (MR) lymphography with gadobutrol contrast for sentinel lymph node (SLN) mapping in early-stage oral squamous cell carcinoma (OSCC). Methods: This pilot study compared the identification of SLNs by MR lymphography using a gadolinium-based contrast agent (gadobutrol) to conventional [99mTc]Tc-nanocolloid lymphoscintigraphy (including single-photon emission computed tomography/computed tomography (SPECT/CT)) in 10 early-stage OSCC patients undergoing SLN biopsy. The patients initially underwent conventional lymphoscintigraphy following the peritumoral administration of indocyanine green [99mTc]Tc-nanocolloid (120 megabecquerel; ~0.5 mL). Subsequently, 0.5–1.0 mL gadobutrol was peritumorally injected, and MR imaging was acquired for 30 min. The following day, the identified SLNs were harvested and subjected to a histopathological assessment. The MR lymphography and [99mTc]Tc-nanocolloid lymphoscintigraphy results were evaluated and compared with respect to those of the SLN identification. The reference standard consisted of a histopathological evaluation of the harvested SLNs, complementary neck dissection specimens, and follow-up data. Results: The MR lymphography detected 16 out of 27 SLNs identified by [99mTc]Tc-nanocolloid lymphoscintigraphy, revealing an additional SLN that did not harbor metastasis. MR lymphography failed to identify any SLNs in one patient. Of the seven histopathologically positive SLNs detected by [99mTc]Tc-nanocolloid lymphoscintigraphy, three were identified by MR lymphography. All patients remained disease-free after a median follow-up of 16 months. Compared to [99mTc]Tc-nanocolloid lymphoscintigraphy, MR lymphography using gadobutrol achieved an SLN identification rate of 59%, a sensitivity of 75%, and a negative predictive value of 86%. Conclusions: MR lymphography using gadobutrol demonstrates limited reliability for SLN mapping in early-stage OSCC.Keywords
This publication has 41 references indexed in Scilit:
- Serial step sections at narrow intervals with immunohistochemistry are required for accurate histological assessment of sentinel lymph node biopsy in oral squamous cell carcinomaHead & Neck, 2021
- Magnetic detection of sentinel nodes in oral squamous cell carcinoma by means of superparamagnetic iron oxide contrastJournal of Surgical Oncology, 2019
- The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- MR lymphography for sentinel lymph node detection in patients with oral cavity cancer: Preliminary clinical studyHead & Neck, 2018
- The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional studyPediatric Radiology, 2016
- PET probe‐guided surgeryJournal of Surgical Oncology, 2007
- Multimodal fusion imaging ensemble for targeted sentinel lymph node management: initial results of an innovative promising approach for anatomically difficult lymphatic drainage in different tumour entitiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Classification of isolated tumor cells and micrometastasisCancer, 1999